Shonak Patel, MD
Vascular Surgery · Pensacola, FLNPI 1215164108
Payments from drug & device makers
Across 236 payments — averaging $62.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Endologix LLC$3K
- Mimedx Group, Inc.$3K
- Medtronic$1K
- Boston Scientific$811
- Stryker$696
- plus $3K from 17 others
What the payments were for
- Travel & lodging$3,37323%
- Food & beverage$11,28377%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 31 | $3,672 |
| Endologix LLC | 17 | $2,875 |
| Mimedx Group, Inc. | 51 | $2,550 |
| Medtronic(2 entities) | 48 | $1,405 |
| Boston Scientific | 15 | $811 |
| Stryker | 1 | $696 |
| Silk Road Medical, Inc. | 12 | $664 |
| Bard Peripheral Vascular, Inc. | 14 | $562 |
| Penumbra, Inc. | 19 | $333 |
| Angiodynamics, Inc. | 2 | $170 |
| Cook Medical LLC | 3 | $164 |
| Davol Inc. | 1 | $142 |
| Philips North America LLC | 1 | $119 |
| Inspiremd Ltd | 2 | $116 |
| Pfizer | 5 | $80 |
| Johnson & Johnson | 4 | $66 |
| Cardiva Medical, Inc. | 2 | $50 |
| TELA Bio, Inc. | 2 | $46 |
| Stability Biologics, LLC | 1 | $34 |
| Veryan Medical Incorporated | 1 | $32 |
| AbbVie | 2 | $31 |
| Kerecis Limited | 1 | $23 |
| Abbott | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ovation$1,406
- GORE TAG Thoracic Endoprosthesis$1,334
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$1,151
- SPY-PHI SYSTEM$696
- ENROUTE Transcarotid Neuroprotection System$659
- AFX$495
- PIVOX Oblique Lateral Spinal System$457
- ALTO$328
- ENDOCROSS Device$293
- Torus Stent Graft System$293
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$223
- ENROUTE Transcarotid Stent System$212
- ENHANCE Transcarotid Peripheral Access Kit$212
- ENROUTE 0.014 Guidewire$212
- VIABAHN VBX Balloon Expandable Endoprosthesis$158
- Phasix Mesh$142
- PHOENIX$119
- Alto Abdominal Stent Graft System$114
- Rotarex$108
- CGuard Prime Carotid Stent System$106
How this compares
$14,656 in reported general payments places this provider in the 65th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 71 | $62,570 |
| XareltoRivaroxaban | 46 | $27,312 |
| ClopidogrelClopidogrel Bisulfate | 376 | $2,953 |
| Cilostazol | 34 | $1,131 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 122 | $1,035 |
| Doxycycline Hyclate | 37 | $470 |
| Gabapentin | 12 | $152 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $78 |
| Tramadol Hcl | 15 | $54 |
| Diazepam | 40 | $32 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $80 | $62,57071 claims |
| Johnson & JohnsonXarelto | $66 | $27,31246 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in Pensacola
- Christopher LecroyPensacola$173K
- Fernando KafiePensacola$155K
- Geoffrey RisleyPensacola$106K
- Huey McDanielPensacola$88K
- James LonquistPensacola$54K
- Samuel TapperStuart$1.3M
- Erin MooreJacksonville$488K
- Mariano ArosemenaBradenton$472K
- Woongchae LeeBoca Raton$414K
- Manuel Perez IzquierdoOrlando$396K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.